Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Jurewitsch, B.
Right arrow Articles by Jeejeebhoy, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jurewitsch, B.
Right arrow Articles by Jeejeebhoy, K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Case Reports

Taurolidine 2% as an Antimicrobial Lock Solution for Prevention of Recurrent Catheter-Related Bloodstream Infections

Brian Jurewitsch, BSCPHM, BCNSP

St Michael's Hospital, Toronto

Tundra Lee, BSCPHM

St Michael's Hospital, Toronto

Joan Park, BSCN,RN

St Michael's Hospital, Toronto

Khursheed Jeejeebhoy, MB, BS, PHD

St Michael's Hospital, Toronto

Background: This case report describes our preliminary data on the use of taurolidine as a lock technique. Taurolidine is a novel antimicrobial agent that has found a niche in Europe for prevention of bacteremia in home parenteral nutrition (HPN) patients who have multiple catheter-related bloodstream infections. Methods: A 29-year-old male with short bowel syndrome was admitted 18 times in 9 years for treatment of Gram-positive, Gram-negative, and yeast-associated catheter-related bloodstream infections. Management consisted of conventional antibiotic treatment in accordance with blood culture and sensitivity results as well as catheter removal in 10 cases. Ten months before the last infection, the patient was instructed to instil 1.5 mL taurolidine 2% daily into his central line after finishing his HPN infusion and has continued to do so 2 years to date. Results: The incidence of catheter-related bloodstream infections decreased from 8.5 to 1.5 infections per 1000 catheter days. Conclusions: These data support previous observations made outside North America and suggest that taurolidine may prove to be an effective and safe antimicrobial agent for the prevention of recurrent catheter-related bloodstream infections. (Journal of Parenteral and Enteral Nutrition 22:242-244, 1998)

Journal of Parenteral and Enteral Nutrition, Vol. 22, No. 4, 242-244 (1998)
DOI: 10.1177/0148607198022004242
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
S. Vescia, A. K. Baumgartner, V. R. Jacobs, M. Kiechle-Bahat, A. Rody, S. Loibl, and N. Harbeck
Management of venous port systems in oncology: a review of current evidence
Ann. Onc., January 1, 2008; 19(1): 9 - 15.
[Abstract] [Full Text] [PDF]

Home page
 Nutr Clin PractHome page
E. A. Krzywda and D. A. Andris
Twenty-five Years of Advances in Vascular Access: Bridging Research to Clinical Practice
Nutr Clin Pract, December 1, 2005; 20(6): 597 - 606.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. S. Garland, C. P. Alex, K. J. Henrickson, T. L. McAuliffe, and D. G. Maki
A Vancomycin-Heparin Lock Solution for Prevention of Nosocomial Bloodstream Infection in Critically Ill Neonates With Peripherally Inserted Central Venous Catheters: A Prospective, Randomized Trial
Pediatrics, August 1, 2005; 116(2): e198 - e205.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Podiatr. Med. Assoc.Home page
D. G. Armstrong, P. Salas, B. Short, B. R. Martin, H. R. Kimbriel, B. P. Nixon, and A. J. M. Boulton
Maggot Therapy in "Lower-Extremity Hospice" Wound Care: Fewer Amputations and More Antibiotic-Free Days
J Am Podiatr Med Assoc, May 1, 2005; 95(3): 254 - 257.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
K. K. Haase, K. A. McCracken, and R. L. Akins
Catheter-Related Bloodstream Infections in the Intensive Care Unit Population
Journal of Pharmacy Practice, February 1, 2005; 18(1): 42 - 52.
[Abstract] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. G. H. Betjes and M. van Agteren
Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution
Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1546 - 1551.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
J. C. Droste, H. A. Jeraj, A. MacDonald, and K. Farrington
Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis
J. Antimicrob. Chemother., April 1, 2003; 51(4): 849 - 855.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. B. Shah, M. W. Mittelman, J. W. Costerton, S. Parenteau, M. Pelak, R. Arsenault, and L. A. Mermel
Antimicrobial Activity of a Novel Catheter Lock Solution
Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1674 - 1679.
[Abstract] [Full Text] [PDF]

Home page
 Nutr Clin PractHome page
E. Steiger and C. Ireton-Jones
The Evolution of Home Parenteral Nutrition in the United States
Nutr Clin Pract, August 1, 2001; 16(4): 236 - 239.
[PDF]